BioCentury
ARTICLE | Clinical News

MSI-78: Interim analysis shows that a Phase III trial should continue, as there were no significant differences between 1 and 2 percent MSI-78 concentrations an

July 3, 1995 7:00 AM UTC

Magainin Pharmaceuticals Inc. (MAGN), Plymouth Meeting, Penn. Product: MSI-78, derivative of the magainin antibiotic peptide found in frog skin, as a 1 or 2 percent topical cream Indication: Diabetic ...